삼성서울병원은 아밀로이드증 다학제진료팀을 최근 아밀로이드증센터로 확대했다고 18일 밝혔다.
Samsung Medical Center announced on the 18th that it has recently expanded the amyloidosis multidisciplinary treatment team to the amyloidosis center.